The benefits of the Hub extend beyond the users who have co-developed the proposal. Our innovations will move the reality of targeted healthcare forward significantly, by identifying the technological and logistical solutions. Targeted interventions will provide a step change for many patients in terms of widened access to new treatments. The range of targets is huge and includes treatments for cancers and the re-programming of degenerative disorders such as dementia. This is a radical new opportunity for the industry. The Hub will deliver the process innovations to enable the rapid and economic development of new clinical medicines and promises a new horizon for the sector.